Last update 23 Jan 2025
Global Regulatory Partners, Inc.

Global Regulatory Partners, Inc.

Private Company|
2010|
Massachusetts, United States
|
10-50
|
globalregulatorypartners.com

Overview

Tags

Endocrinology and Metabolic Disease
Fusion protein
Hormone
Biosimilar

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Hormone1
Biosimilar1
Fusion protein1
Top 5 TargetCount
PGF x VEGF-A1
GCGR(Glucagon receptor)1

Related

2
Drugs associated with Global Regulatory Partners, Inc.
Glucagon
Target
GCGR
Mechanism
GCGR agonists
Active Org.
Amphastar France Pharmaceuticals SAS [+5]
Originator Org.
Eli Lilly & Co.Eli Lilly & Co.
Active Indication
Diabetes Mellitus [+1]
Inactive Indication
Common Cold [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date14 Nov 1960
Aflibercept Biosimilar(GRP)
Target
PGF x VEGF-A
Mechanism
PGF inhibitors [+1]
Active Org.
Global Regulatory Partners, Inc.Global Regulatory Partners, Inc.
Originator Org.-
Active Indication-
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date29 Aug 2024
100 Clinical Results associated with Global Regulatory Partners, Inc.
Login to view more data
0 Patents (Medical) associated with Global Regulatory Partners, Inc.
Login to view more data
100 Deals associated with Global Regulatory Partners, Inc.
Login to view more data
100 Translational Medicine associated with Global Regulatory Partners, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Glucagon
 ( GCGR )		Hypoglycemia
More
Approved
Aflibercept Biosimilar(GRP)
 ( PGF x VEGF-A )		-
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free